{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:58:14Z","timestamp":1787590694570,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:00:00Z","timestamp":1717113600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.xkme.2024.100850","type":"journal-article","created":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T01:02:08Z","timestamp":1717722128000},"page":"100850","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Matrix Metalloproteinase-2 and CKD Progression: The Chronic Renal Insufficiency Cohort (CRIC) Study"],"prefix":"10.1016","volume":"6","author":[{"given":"Robin L.","family":"Baudier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula F.","family":"Orlandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiang-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Walker","family":"Blackston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajat","family":"Deo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirela","family":"Dobre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C.","family":"Ricardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq","family":"Shafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Susztak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold I.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda H.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence J.","family":"Appel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Dember","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan S.","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Lash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboob","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panduranga S.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vallabh O.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark L.","family":"Unruh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xkme.2024.100850_bib1","series-title":"Chronic Kidney Disease in the United States","year":"2021"},{"issue":"10075","key":"10.1016\/j.xkme.2024.100850_bib2","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic kidney disease","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.xkme.2024.100850_bib3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev-physiol-022516-034227","article-title":"Mechanisms of renal fibrosis","volume":"80","author":"Humphreys","year":"2018","journal-title":"Annu Rev Physiol"},{"issue":"15","key":"10.1016\/j.xkme.2024.100850_bib4","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2174\/0929867325666171205143441","article-title":"Role of matrix metalloproteinases in degenerative kidney disorders","volume":"25","author":"Narula","year":"2018","journal-title":"Curr Med Chem"},{"issue":"1","key":"10.1016\/j.xkme.2024.100850_bib5","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12882-017-0490-0","article-title":"Biomarkers for the detection of renal fibrosis and prediction of renal outcomes: a systematic review","volume":"18","author":"Mansour","year":"2017","journal-title":"BMC Nephrol"},{"issue":"6","key":"10.1016\/j.xkme.2024.100850_bib6","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1007\/s10157-015-1221-0","article-title":"Decreases in plasma MMP-2\/TIMP-2 and MMP-9\/TIMP-1 ratios in uremic patients during hemodialysis","volume":"20","author":"Lu","year":"2016","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.xkme.2024.100850_bib7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1515\/med-2018-0037","article-title":"MMP-2 and TIMP-2 in patients with heart failure and chronic kidney disease","volume":"13","author":"Kobusiak-Prokopowicz","year":"2018","journal-title":"Open Med (Wars)"},{"issue":"4","key":"10.1016\/j.xkme.2024.100850_bib8","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/ndt\/gfl743","article-title":"Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis","volume":"22","author":"Bauvois","year":"2007","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.xkme.2024.100850_bib9","doi-asserted-by":"crossref","first-page":"F1927","DOI":"10.1152\/ajprenal.00310.2007","article-title":"Urinary matrix metalloproteinases reflect renal damage in anti-neutrophil cytoplasm autoantibody-associated vasculitis","volume":"293","author":"Sanders","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"issue":"7","key":"10.1016\/j.xkme.2024.100850_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070132","article-title":"Progression of kidney disease in non-diabetic patients with coronary artery disease: predictive role of circulating matrix metalloproteinase-2, -3, and -9","volume":"8","author":"Hsu","year":"2013","journal-title":"PLOS ONE"},{"issue":"3","key":"10.1016\/j.xkme.2024.100850_bib11","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2337\/dc16-2202","article-title":"Systems biology-derived biomarkers to predict progression of renal function decline in type 2 diabetes","volume":"40","author":"Mayer","year":"2017","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.xkme.2024.100850_bib12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1053\/j.ajkd.2014.02.020","article-title":"Early change in proteinuria as a surrogate end point for kidney disease progression: an individual patient meta-analysis","volume":"64","author":"Inker","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.xkme.2024.100850_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/biom10010154","article-title":"The association of matrix metalloproteinases with chronic kidney disease and peripheral vascular disease: A light at the end of the tunnel?","volume":"10","author":"Provenzano","year":"2020","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.xkme.2024.100850_bib14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000151439","article-title":"Circulating matrix metalloproteinase-2 is an independent correlate of proteinuria in patients with chronic kidney disease","volume":"29","author":"Nagano","year":"2009","journal-title":"Am J Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2024.100850_bib15","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.kint.2018.08.024","article-title":"Aldosterone induces albuminuria via matrix metalloproteinase-dependent damage of the endothelial glycocalyx","volume":"95","author":"Butler","year":"2019","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.xkme.2024.100850_bib16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1681\/ASN.V93397","article-title":"Inhibition of matrix metalloproteinases attenuates anti-Thy1.1 nephritis","volume":"9","author":"Steinmann-Niggli","year":"1998","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2024.100850_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030100","article-title":"Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease","volume":"3","author":"Zeisberg","year":"2006","journal-title":"PLOS Med"},{"issue":"5","key":"10.1016\/j.xkme.2024.100850_bib18","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.kint.2019.09.035","article-title":"Blocking matrix metalloproteinase-mediated syndecan-4 shedding restores the endothelial glycocalyx and glomerular filtration barrier function in early diabetic kidney disease","volume":"97","author":"Ramnath","year":"2020","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.xkme.2024.100850_bib19","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/EDE.0000000000001469","article-title":"The case for case-cohort: an applied epidemiologist\u2019s guide to reframing case-cohort studies to improve usability and flexibility","volume":"33","author":"O\u2019Brien","year":"2022","journal-title":"Epidemiology"},{"issue":"3","key":"10.1016\/j.xkme.2024.100850_bib20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/aje\/kwi187","article-title":"When is baseline adjustment useful in analyses of change? An example with education and cognitive change","volume":"162","author":"Glymour","year":"2005","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.xkme.2024.100850_bib21","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/EDE.0b013e3181a819a1","article-title":"Overadjustment bias and unnecessary adjustment in epidemiologic studies","volume":"20","author":"Schisterman","year":"2009","journal-title":"Epidemiology"},{"issue":"12","key":"10.1016\/j.xkme.2024.100850_bib22","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0895-4356(99)00102-X","article-title":"Analysis of case-cohort designs","volume":"52","author":"Barlow","year":"1999","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"2","key":"10.1016\/j.xkme.2024.100850_bib23","first-page":"299","article-title":"Expressions and clinical significance of factors related to acute coronary syndrome","volume":"32","author":"Sun","year":"2018","journal-title":"J\u00a0Biol Regul Homeost Agents"},{"issue":"6","key":"10.1016\/j.xkme.2024.100850_bib24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1445-5994.2005.00822.x","article-title":"Elevated circulating levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery disease","volume":"35","author":"Zeng","year":"2005","journal-title":"Intern Med J"},{"issue":"1","key":"10.1016\/j.xkme.2024.100850_bib25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.arcmed.2008.10.011","article-title":"Metalloproteases 2 and 9, Lp-PLA(2) and lipoprotein profile in coronary patients","volume":"40","author":"Muzzio","year":"2009","journal-title":"Arch Med Res"},{"issue":"2","key":"10.1016\/j.xkme.2024.100850_bib26","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s11255-009-9683-1","article-title":"Serum metalloproteinases MMP-2, MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in patients on hemodialysis","volume":"43","author":"Rysz","year":"2011","journal-title":"Int Urol Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2024.100850_bib27","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1159\/000065464","article-title":"Serum matrix metalloproteinases MMP-2 and MMP-3 levels in dialysis patients vary independently of CRP and IL-6 levels","volume":"92","author":"Preston","year":"2002","journal-title":"Nephron"},{"issue":"10-11","key":"10.1016\/j.xkme.2024.100850_bib28","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.clinbiochem.2011.03.143","article-title":"Peripheral blood level alterations of MMP-2 and MMP-9 in patients with chronic kidney disease on conservative treatment and on hemodialysis","volume":"44","author":"Pawlak","year":"2011","journal-title":"Clin Biochem"},{"issue":"3","key":"10.1016\/j.xkme.2024.100850_bib29","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1160\/TH04-02-0128","article-title":"Extrinsic coagulation pathway activation and metalloproteinase-2\/TIMPs system are related to oxidative stress and atherosclerosis in hemodialysis patients","volume":"92","author":"Pawlak","year":"2004","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.xkme.2024.100850_bib30","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.thromres.2007.06.008","article-title":"Urokinase-type plasminogen activator and metalloproteinase-2 are independently related to the carotid atherosclerosis in haemodialysis patients","volume":"121","author":"Pawlak","year":"2008","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.xkme.2024.100850_bib31","doi-asserted-by":"crossref","first-page":"c251","DOI":"10.1159\/000313483","article-title":"Systemic levels of MMP2\/TIMP2 and cardiovascular risk in CAPD patients","volume":"115","author":"Pawlak","year":"2010","journal-title":"Nephron Clin Pract"},{"issue":"7","key":"10.1016\/j.xkme.2024.100850_bib32","article-title":"The possible effect of beta-blocker use on the circulating MMP-2\/TIMP-2 system in patients with chronic kidney disease on conservative treatment","volume":"13","author":"Kopanko","year":"2024","journal-title":"J\u00a0Clin Med"},{"issue":"4","key":"10.1016\/j.xkme.2024.100850_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18040776","article-title":"MMP-2 and 9 in Chronic kidney disease","volume":"18","author":"Cheng","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.xkme.2024.100850_bib34","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000243050","article-title":"Fibroblast growth factor 23 and matrix-metalloproteinases in patients with chronic kidney disease: are they associated with cardiovascular disease?","volume":"32","author":"Peiskerova","year":"2009","journal-title":"Kidney Blood Press Res"},{"issue":"9","key":"10.1016\/j.xkme.2024.100850_bib35","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/ndt\/gfab251","article-title":"Serum matrix metalloproteinase 7 and accelerated glomerular filtration rate decline in a general non-diabetic population","volume":"37","author":"Enoksen","year":"2022","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.xkme.2024.100850_bib36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/res.90.3.251","article-title":"Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly","volume":"90","author":"Galis","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.xkme.2024.100850_bib37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/bs.pmbts.2017.03.001","article-title":"Matrix metalloproteinases in kidney disease: role in pathogenesis and potential as a therapeutic target","volume":"148","author":"Parrish","year":"2017","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"4","key":"10.1016\/j.xkme.2024.100850_bib38","first-page":"292","article-title":"Matrix metalloproteinases, atherosclerosis, proteinuria and kidney disease: linkage-based approaches","volume":"17","author":"Dimas","year":"2013","journal-title":"Hippokratia"},{"issue":"8","key":"10.1016\/j.xkme.2024.100850_bib39","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41581-021-00415-5","article-title":"Key metalloproteinase-mediated pathways in the kidney","volume":"17","author":"Wozniak","year":"2021","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"10.1016\/j.xkme.2024.100850_bib40","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/jvim.15454","article-title":"The renin-angiotensin-aldosterone system and its suppression","volume":"33","author":"Ames","year":"2019","journal-title":"J\u00a0Vet Intern Med"},{"issue":"6","key":"10.1016\/j.xkme.2024.100850_bib41","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/ki.1993.378","article-title":"Captopril inhibits the 72 kDa and 92 kDa matrix metalloproteinases","volume":"44","author":"Sorbi","year":"1993","journal-title":"Kidney Int"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259005952400061X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259005952400061X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T03:37:16Z","timestamp":1728531436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S259005952400061X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S259005952400061X"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2024.100850","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Matrix Metalloproteinase-2 and CKD Progression: The Chronic Renal Insufficiency Cohort (CRIC) Study","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2024.100850","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"100850"}}